Iranian Society of Gynecology Oncology

Document Type : Original Research Article


1 Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran

2 Department of Anesthesiology, Pain Research Center, Iran University of Medical Sciences, Tehran, Iran

3 Iran University of Medical Sciences, Tehran, Iran


Background & Objective: Hysterectomy is the most common gynecological surgery. Every year, numerous women around the world undergo this type of surgery for various reasons. Regardless of the type of surgery, bleeding during surgery and after surgery is the most common consequence? Tranexamic acid is a cheap, available and low-complication drug that has been considered in recent years to control bleeding. The present study investigated the effectiveness of Tranexamic acid on the bleeding during laparotomy hysterectomy in women aged 35 to 55 years.
Materials & Methods: This study was a randomized, double-blind clinical trial performed on 80 patients undergoing laparotomy hysterectomy. Using a random number table, patients were divided into two groups A (receiving Transid) and the other group receiving drug B (not receiving Transid), both of which received 100 ml of normal saline prepared to reduce bias in the prepared syringe.
Results: Mean age of the patients was 46.24 ± 5.21 years. Based on the results of mean hemoglobin before surgery, the rate of infection, infusion and induction in the control and intervention groups were not statistically different (P > 0.05). Also, the mean hemoglobin variables before and after hemorrhage were estimated by the surgeon and hemorrhage estimated according to Hernandez formula were not statistically different in the two groups (P > 0.05).
Conclusion: Tranexamic acid administration has no effect on the amount of bleeding during hysterectomy laparotomy.


 Tranexamic acid administration has no effect on the amount of bleeding during hysterectomy laparotomy.


Main Subjects

1. Topsoee MF, Bergholt T, Ravn P, Schouenborg L, Moeller C, Ottesen B, et al. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. Am J Obstet Gynecol. 2016;215(1):72.e1-.e8. [DOI:10.1016/j.ajog.2016.01.184] [PMID]
2. Salman MA, Ercan Yücebaş M, Coşkun F, Aypar Ü. Day-case laparoscopy: a comparison of prophylactic opioid, NSAID or local anesthesia for postoperative analgesia. Acta Anaesthesiol Scand. 2000;44(5):536-42. [DOI:10.1034/j.1399-6576.2000.00508.x] [PMID]
3. Novak E. Berek & Novak's gynecology: Lippincott Williams & Wilkins; 2007.
4. Zohar E, Shapiro A, Phillipov A, Hoppenstein D, Klein Z, Fredman B. The postoperative analgesic efficacy of wound instillation with ropivacaine 0.1% versus ropivacaine 0.2%. J Clin Anesth. 2004;16(6):399-404. [DOI:10.1016/j.jclinane.2004.07.002] [PMID]
5. Aarts JWM, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BWJ, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015(8). [DOI:10.1002/14651858.CD003677.pub5] [PMID] [PMCID]
6. Maresh MJA, Metcalfe MA, McPherson K, Overton C, Hall V, Hargreaves J, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG: Int J Obstet Gynaecol. 2002;109(3):302-12. [DOI:10.1111/j.1471-0528.2002.01282.x] [PMID]
7. Parashi S, Astaraei V, Vahdat M, Dini P, Mohammadianamiri M. The Effect of a Single Preoperative dose of sublingual misoprostol in reducing intraoperative blood loss after total abdominal hysterectomy: a single-blind randomized controlled trial. J Obstet Gynecol Cancer Res. 2022;3(4):143-7. [DOI:10.30699/jogcr.3.4.7]
8. Klebanoff JS, Marfori CQ, Ingraham CF, Wu CZ, Moawad GN. Applications of Tranexamic acid in benign gynecology. Curr Opin Obstet Gynecol. 2019;31(4):235-9. [DOI:10.1097/GCO.0000000000000547] [PMID]
9. Ballinger A. Essentials of Kumar and Clark's Clinical Medicine E-Book: Elsevier Health Sciences; 2011.
10. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I, Collaborators CT. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011;6(5):e18987. [DOI:10.1371/journal.pone.0018987] [PMID] [PMCID]
11. Clavé A, Gérard R, Lacroix J, Baynat C, Des Déserts MD, Gatineau F, et al. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J. 2019;101(2):207-12. [DOI:10.1302/0301-620X.101B2.BJJ-2018-0898.R1] [PMID]
12. Chaudhary FA, Pervaz Z, Ilyas S, Niaz MN. Topical use of tranexamic acid in open heart surgery. J Pak Med Assoc. 2018;68(4):538-42.
13. Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine J. 2008;33(24):2577-80. [DOI:10.1097/BRS.0b013e318188b9c5] [PMID]
14. Choi WS, Irwin MG, Samman N. The Effect of Tranexamic Acid on Blood Loss During Orthognathic Surgery: A Randomized Controlled Trial. J Oral Maxillofac Surg. 2009;67(1):125-33. [DOI:10.1016/j.joms.2008.08.015] [PMID]
15. Aghadavoudi O, Bonakdar-Hashemi M, Hashempour H. The Effect of Intravenous Tranexamic Acid on Perioperative Bleeding and Surgeon's Satisfaction during Mastoidectomy. J Isfahan Med Sch. 2017;34(415):1653-9.
16. Mohammadi Sichani M, Kazemi R, Nouri-Mahdavi K, Gholipour F. Re-evaluation of the efficacy of tranexamic acid in reducing blood loss in percutaneous nephrolithotomy: a randomized clinical trial. Minerva Urol Nefrol. 2019;71(1):55-62. [DOI:10.23736/S0393-2249.18.03151-X] [PMID]
17. Abrisham SMJ, Sobhan Mr, Golkar-Khouzani E, Sonbolestan SA. The Effect of Topical Tranexamic Acid versus Injection into the Clamped Drain on Postsurgical Bleeding in Knee Arthroplasty Surgery: A Double-Blind Randomized Clinical Trial Study. J Isfahan Med Sch. 2018;36(499):1206-12.
18. D'Ambra MN, Akins CW, Blackstone EH, Bonney SL, Cohn LH, Cosgrove DM, et al. Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg. 1996;112(4):1081-9. [DOI:10.1016/S0022-5223(96)70110-1] [PMID]
19. Haddadi S, Parvizi A, Fadaee Naiini A, Atkar roshan Z, Arghand S, Naderi nabi B. Efficacy of the prophylactic dose of tranexamic acid in the amount of blood during mandibular surgeries. Anesthesiology Pain. 2015;6(1):16-24.
20. Dakir A, Ramalingam B, Ebenezer V, Dhanavelu P. Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery-A Pilot Study. J Clin Diagn Res. 2014;8(5):Zc06-8. [DOI:10.7860/JCDR/2014/8680.4313] [PMID] [PMCID]
21. Ockerman A, Vanassche T, Garip M, Vandenbriele C, Engelen MM, Martens J, et al. Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review. Thromb J. 2021;19(1):54. [DOI:10.1186/s12959-021-00303-9] [PMID] [PMCID]
22. Wong J, El Beheiry H, Rampersaud YR, Lewis S, Ahn H, De Silva Y, et al. Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg. 2008;107(5):1479-86. [DOI:10.1213/ane.0b013e3181831e44] [PMID]
23. Shakur H, Roberts I, Edwards P, Elbourne D, Alfirevic Z, Ronsmans C. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial. Trials. 2016;17(1):249. [DOI:10.1186/s13063-016-1332-2] [PMID] [PMCID]
24. Sallam HF, Shady NW. Reducing blood loss during abdominal hysterectomy with intravenous versus topical tranexamic acid: a double-blind randomized controlled trial. J Obstet Gynaecol India. 2019;69:173-9. [DOI:10.1007/s13224-018-1149-x] [PMID] [PMCID]
25. Traylor J, Runge M, Friedman J, Nixon KE, Tsai SC, Chaudhari A, et al. Intravenous Tranexamic Acid Prior to Hysterectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial. J Minim Invasive Gynecol. 2020;27(7):S5. [DOI:10.1016/j.jmig.2020.08.035]
26. Almassinokiani F, Alimian M, Hamednasimi P. The effect of single dose Tranexamic acid on hemorrhagia during abdominal hysterectomy. J Obstet Gynecol Cancer Res. 2022(14):27.
27. Aghakhani K, Soltani S, Memarian A, Shahrokh Mehrpisheh S. The Relationship between Demographic Indicators and Mortality Rate of Covid-19 Disease Comparatively and Retrospectively in Different Waves of Covid-19 Disease in Iran. J Exp Clin Med. 2022;39(4):1038-42. [DOI:10.52142/omujecm.39.4.22]
28. Barzegar A, Ghadipasha M, Rezaei N, Forouzesh M. New hope for treatment of respiratory involvement following COVID-19 by bromhexine. J Nephropharmacol. 2021;10(2):e11. [DOI:10.34172/npj.2021.11]
29. Besharat S, Malekpour Alamda N, Dadashzadeh N, Talaie R, Mousavi SS, Barzegar A, et al. Clinical and Demographic Characteristics of Patients with COVID-19 Who Died in Modarres Hospital. Open Access Maced. J Med Sci. 2020;8(T1):144-9. [DOI:10.3889/oamjms.2020.5013]
30. Tabatabaii SA, Soltani P, Khanbabaee G, Sharma D, Valizadeh R, Farahbakhsh N, et al. SARS Coronavirus 2, severe acute respiratory syndrome, and middle east respiratory syndrome in children: A review on epidemiology, clinical presentation, and diagnosis. Arch Pediatr Infect Dis. 2020;8(4):1-8. [DOI:10.5812/apid.104860]
31. Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is coronavirus disease 2019 (COVID-19) associated with renal involvement? A review of century infection. Jundishapur J Microbiol. 2020;13(4):1-6. [DOI:10.5812/jjm.102899]
32. Ogawa H, Asakura H. Consideration of Tranexamic Acid Administration to COVID-19 Patients. Physiol Rev. 2020;100(4):1595-6. [DOI:10.1152/physrev.00023.2020] [PMID] [PMCID]
33. Mirshamsi M, Ghiasi N, Heidari S, Hosseinpour P, Hassanlouei B, Hashemipour SMA, et al. Conjunctivitis and other ocular manifestation following COVID-19; updated information about transmission of COVID-19 by eye. Immunopathol Persa. 2021;7(2):e28. [DOI:10.34172/ipp.2021.28]
34. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. [DOI:10.1111/jth.14768] [PMID] [PMCID]